000 | 01045 a2200325 4500 | ||
---|---|---|---|
005 | 20250511185854.0 | ||
264 | 0 | _c19930222 | |
008 | 199302s 0 0 eng d | ||
022 | _a0093-7754 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSplinter, T A | |
245 | 0 | 0 |
_aWhat is the optimal dose and duration of treatment with etoposide? I. Maximum tolerated duration of daily treatment with 50, 75, and 100 mg of oral etoposide. _h[electronic resource] |
260 |
_bSeminars in oncology _cDec 1992 |
||
300 |
_a1-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
700 | 1 | _avan der Gaast, A | |
700 | 1 | _aKok, T C | |
773 | 0 |
_tSeminars in oncology _gvol. 19 _gno. 6 Suppl 14 _gp. 1-7 |
|
999 |
_c1495134 _d1495134 |